HUTCHMED (China) Ltd (HCM)
16.75
-0.10
(-0.59%)
USD |
NASDAQ |
Nov 15, 16:00
16.75
0.00 (0.00%)
After-Hours: 20:00
HUTCHMED Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2021 | 75.81M |
| March 31, 2021 | 81.56M |
| June 30, 2020 | 55.20M |
| March 31, 2020 | 51.57M |
| June 30, 2019 | 50.03M |
| March 31, 2019 | 52.17M |
| Date | Value |
|---|---|
| June 30, 2018 | 49.85M |
| March 31, 2018 | 52.34M |
| December 31, 2015 | 56.28M |
| September 30, 2015 | 39.44M |
| December 31, 2014 | 29.08M |
| September 30, 2014 | 27.92M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
51.57M
Minimum
Mar 2020
81.56M
Maximum
Mar 2021
66.03M
Average
65.50M
Median
Revenue (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 7.918B |
| AstraZeneca PLC | 12.94B |
| Sino Biopharmaceutical Ltd | -- |
| Regencell Bioscience Holdings Ltd | -- |
| Prenetics Global Ltd | 5.942M |
Revenue (Quarterly) Related Metrics
| Enterprise Value | 2.171B |
| Earnings Yield | -1.49% |
| Normalized Earnings Yield | -1.493 |